J. Maynar

发表

Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study

A. Isla, A. Rodríguez-Gascón, M. Solinís, 2022, Journal of Intensive Care.

Population Pharmacokinetics of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

I. Trocóniz, J. Pedraz, A. Isla, 2008, Clinical pharmacokinetics.

UPDATE IN INTENSIVE CARE : HEMODYNAMIC MONITORING IN CRITICALLY ILL PATIENTS Assessment of cardiovascular preload and response to volume expansion

A. Ochagavía, J. Maynar, C. Sabatier, 2012 .

Mechanical thrombectomy in patients with tumour-related ischaemic stroke

M. Maynar, T. Zander, J. Maynar, 2016, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.

Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation

A. Isla, A. Rodríguez-Gascón, Helena Barrasa, 2020, Pharmaceutics.

Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: Influence of residual renal function on PK/PD target attainment

A. Canut, A. Isla, A. Rodríguez-Gascón, 2019, Journal of critical care.

The value of open-source clinical science in pandemic response: lessons from ISARIC

Siti Zubaidah Othman, Karl Erik Müller, Jose M. Mandei, 2021, The Lancet Infectious Diseases.

Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study

C. A. Shaw, Eglantine Ferrand Devouge, Su Hwan Lee, 2022, Critical Care.

Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function

A. Rodríguez-Gascón, M. Solinís, I. Bilbao-Meseguer, 2021, Pharmaceutics.

In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes.

A. R. Gascón, J. L. Pedraz Muñoz, A. Isla, 2005, Clinical therapeutics.

Intrapericardial streptokinase fibrinolysis in the management of purulent pneumococcal pericarditis.

J. Maynar, M. Ulibarrena, F. Labayen, 1997, Intensive care medicine.

Predicting fluid responsiveness in ICU patients: comparison of different parameters and cutoff limits using pulse power analysis assessment

Helena Barrasa, J. Maynar, F. Fonseca, 2015, Critical Care.

[Assessment of cardiovascular preload and response to volume expansion].

A. Ochagavía, J. Maynar, C. Sabatier, 2012, Medicina intensiva.

Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients

Siti Zubaidah Othman, Eyvind W. Axelsen, C. A. Shaw, 2022, Influenza and other respiratory viruses.

Impact of augmented renal clearance (ARC) on the pharmacokinetics of linezolid: Advantages of continuous infusion from a PK/PD perspective.

A. Isla, A. Rodríguez-Gascón, Helena Barrasa, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

In vitro AN69 and Polysulphone Membrane Permeability to Ceftazidime and in vivo Pharmacokinetics during Continuous Renal Replacement Therapies

J. Pedraz, A. R. Gascón, A. Isla, 2007, Chemotherapy.

Meropenem and Continuous Renal Replacement Therapy: In Vitro Permeability of 2 Continuous Renal Replacement Therapy Membranes and Influence of Patient Renal Function on the Pharmacokinetics in Critically Ill Patients

J. Pedraz, A. R. Gascón, A. Isla, 2005, Journal of clinical pharmacology.

Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.

J. Pedraz, A. R. Gascón, A. Isla, 2005, Clinical therapeutics.

Influence of Renal Function on the Pharmacokinetics of Piperacillin/Tazobactam in Intensive Care Unit Patients During Continuous Venovenous Hemofiltration

J. Rello, J. Pedraz, A. R. Gascón, 2005, Journal of clinical pharmacology.

Determination of ceftazidime and cefepime in plasma and dialysate-ultrafiltrate from patients undergoing continuous veno-venous hemodiafiltration by HPLC.

J. Pedraz, A. R. Gascón, A. Isla, 2005, Journal of pharmaceutical and biomedical analysis.

Elimination of Piperacillin and Tazobactam by Renal Replacement Therapies with AN69 and Polysulfone Hemofilters: Evaluation of the Sieving Coefficient

J. Pedraz, A. R. Gascón, A. Isla, 2006, Blood Purification.

Direct hemoperfusion with polymyxin B-immobilized cartridge in severe sepsis due to intestinal perforation: hemodynamic findings and clinical considerations in anticoagulation therapy.

M. Herrera-Gutiérrez, F. J. Candel, J. Maynar, 2013, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC.

J. Pedraz, A. R. Gascón, A. Isla, 2005, Biomedical chromatography : BMC.

[Non-beating heart donors--Maastricht type III: a real option].

J. Maynar, I. Saralegui, E. Corral, 2011, Medicina intensiva.

Infections I

D. Grujičić, T. Inglis, C. Brun-Buisson, 2011, Intensive Care Medicine.

ACUsmart Continuous Renal Replacement Therapy Platform: Multicenter Pilot Study for Technical and Clinical Assessment (A.M.P. Study)

C. Ronco, G. Auzinger, A. Lorenzin, 2019, Blood Purification.

SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria

J. Rello, A. Villagrá, B. Fernández-Miret, 2020, Anaesthesia Critical Care & Pain Medicine.

Quantification of Ceftaroline in Human Plasma Using High-Performance Liquid Chromatography with Ultraviolet Detection: Application to Pharmacokinetic Studies

A. Isla, A. Rodríguez-Gascón, M. Solinís, 2021, Pharmaceutics.